Rojkjaer Lisa (CIK 0001846460)

Latest company ownership

VIRX - Viracta Therapeutics, Inc.

Role: Chief Medical Officer

Shares held

150,000

Last filed at

Mar 17, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2021Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Feb 25, 2023	Feb 28, 2023	Viracta Therapeutics, Inc.	Chief Medical Officer	Sell	47.5	-2,156	-4.29%	✗	$3.6K
Nov 25, 2022	Nov 29, 2022	Viracta Therapeutics, Inc.	Chief Medical Officer	Sell	47.5	-2,116	-4.39%	✗	$5.8K
Aug 25, 2022	Aug 29, 2022	Viracta Therapeutics, Inc.	Chief Medical Officer	Sell	47.5	-2,190	-4.73%	✗	$8.8K
May 25, 2022	May 27, 2022	Viracta Therapeutics, Inc.	Chief Medical Officer	Sell	47.5	-2,154	-4.86%	✗	$4.1K
Feb 25, 2022	Mar 1, 2022	Viracta Therapeutics, Inc.	Chief Medical Officer	Sell	47.5	-2,395	-5.62%	✗	$6.7K
Nov 25, 2021	Nov 29, 2021	Viracta Therapeutics, Inc.	Chief Medical Officer	Sell	46.3	-4,541	-10.56%	✗	$21.8K